PR Newswire
AUSTIN, Texas, July 27, 2017
AUSTIN, Texas, July 27, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its second quarter 2017 financial results on Tuesday, August 8, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.
Tuesday, August 8th @ 4:30pm Eastern Time | |
Domestic: | 888-437-9274 |
International: | 719-325-2437 |
Conference ID: | 8515049 |
Webcast: | |
| |
Replays, Available through August 22nd | |
Domestic: | 844-512-2921 |
International: | 412-317-6671 |
Replay PIN: | 8515049 |
About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.
Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com
View original content:http://www.prnewswire.com/news-releases/vermillion-to-report-second-quarter-2017-financial-results-and-host-investor-conference-call-on-august-8th-300495663.html
SOURCE Vermillion, Inc.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.